Adam M. LaBaff
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 2
- Geriatrics and Gerontology top 5%
- Oncology top 10%
- Cancer Cells and Metastasis 4
-
- Histone Deacetylase Inhibitors Research 2
- Epigenetics and DNA Methylation 2
- Pluripotent Stem Cells Research 1
- RNA modifications and cancer 1
-
- Autophagy in Disease and Therapy 1
-
- Genetic Syndromes and Imprinting 1
Adam M. LaBaff
8 papers receiving 883 citations
Peers
Comparison fields: 5 of 75
- Cancer Research 376
- Geriatrics and Gerontology 66
- Oncology 355
- Molecular Biology 576
- Physiology 22
Countries citing papers authored by Adam M. LaBaff
This map shows the geographic impact of Adam M. LaBaff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam M. LaBaff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam M. LaBaff more than expected).
Fields of papers citing papers by Adam M. LaBaff
This network shows the impact of papers produced by Adam M. LaBaff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam M. LaBaff. The network helps show where Adam M. LaBaff may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Adam M. LaBaff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 44 | |
| 2 | 2016 | 34 | |
| 3 | Phosphorylation of EZH2 at T416 by CDK2 contributes to the malignancy of triple negative breast cancers. | 2015 | 40 |
| 4 | 2014 | 76 | |
| 5 | 2013 | 74 | |
| 6 | 2012 | 389 | |
| 7 | Long non-coding RNAs: versatile master regulators of gene expression and crucial players in cancer. | 2012 | 203 |
| 8 | 2010 | 34 |
About Adam M. LaBaff
Adam M. LaBaff is a scholar working on Geriatrics and Gerontology, Oncology and Cancer Research, having authored 8 papers that have together received 894 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (4 papers), Histone Deacetylase Inhibitors Research (2 papers), Epigenetics and DNA Methylation (2 papers), Cancer-related molecular mechanisms research (2 papers), Autophagy in Disease and Therapy (1 paper), Genetic Syndromes and Imprinting (1 paper), Pluripotent Stem Cells Research (1 paper) and RNA modifications and cancer (1 paper). The work is most often cited by research in Cancer Research (376 citations), Geriatrics and Gerontology (66 citations) and Oncology (355 citations). Adam M. LaBaff has collaborated with scholars based in United States, Taiwan and Japan. Frequent co-authors include Mien‐Chie Hung, Jennifer L. Hsu, Chia‐Wei Li, Weiya Xia, Lei Nie, Hirohito Yamaguchi, Seung-Oe Lim, Longfei Huo, Gabriel N. Hortobágyi and Hsing‐Ju Wu. Their work appears in journals such as Cancer Research, Oncogene and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.